Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. Powles T, Valderrama BP, Gupta S, Bedke J, et al. N Engl J Med 2024;390:875-888.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Powles T, Valderrama BP, Gupta S, Bedke J, et al. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med 2024;390:875-888.
PMID: 38446675